Custom service
Custom Membrane Protein Production
A full project, from a sequence to a protein with a function you can measure.
A custom membrane protein project is not a service item; it is a small research programme with a deadline. It begins with a question most vendors skip: what will the protein be used for, and what measurement will define success? A preparation for structural biology needs milligrams of monodisperse protein in one conformational state; a preparation for antibody immunisation needs the native surface presented in a lipid environment; a preparation for assay development needs function. The answer changes the construct, the host and the format.
The campaign is staged, and each stage has a decision point. The expression screen answers whether the target is tractable. The extraction screen answers which environment holds it. The purification stage delivers the protein in the required format, and the QC stage measures whatever the original question demanded — monodispersity, stability, ligand binding, transport or catalysis. At each decision point the data decide whether to continue, redesign or stop.
Stopping is a legitimate outcome, and saying so early is cheaper than pretending otherwise. Some membrane proteins cannot yet be produced in a functional state by anyone; the expression screen identifies those within six weeks, and the honest report is more useful than a purification that yields an inactive protein with a clean chromatogram.
Custom production is the right choice for high-value targets where the answer matters: therapeutic candidates, difficult families for antibody programmes, and proteins intended for structural work.
It is over-scoped for a target with an existing published protocol, where reproducing the known condition is faster than re-deriving it. We will say so and quote a reproduction instead of a campaign.
Each stage gate is documented with its data and decision. The final batch carries the QC measurement agreed in scoping, plus SEC-MALS, thermal stability and identity by mass spectrometry. The campaign report includes every screen result, including the failed conditions.
Service Highlights
- Goal-led design. Construct, host and format chosen against the intended use, stated in the project plan before work begins.
- Staged decision points. Expression, extraction, purification and QC each gated by data, with a go/stop decision documented at every stage.
- Parallel construct strategy. Boundaries, tags and stabilising mutations tested simultaneously rather than sequentially.
- Format flexibility. Detergent, nanodisc, amphipol and liposome formats from a single purified batch.
- Functional acceptance. The batch is judged on the measurement agreed at the start, not on yield alone.
- Full documentation. Construct sequences, screening data and process parameters supplied, so the campaign can be continued or transferred.
How the work runs
Project scoping
Intended use, success criteria and constraints defined; a written project plan with staged decision points is issued.
Construct design and synthesis
Variant panel designed against the biology and synthesised with tags and cleavage sites.
Expression screen
Hosts and constructs compared by expression and by functional or binding readout.
Extraction and purification
Best condition scaled up; affinity capture, SEC and format exchange to the required delivery format.
Functional QC
The success measurement agreed in scoping is run on the final batch.
Reporting and archive
Full campaign report, constructs and screening data transferred or archived for future work.
Specifications & timeline
- Scope
- Custom projects from sequence to validated batch
- Target classes
- GPCRs, ion channels, transporters, membrane enzymes, viral envelope proteins
- Formats
- Detergent micelles, nanodiscs, amphipols, proteoliposomes
- Scale
- 0.1–10 mg per batch
- Timeline
- 10–20 weeks depending on target and depth
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.